Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2B6 | P20813 | 1/20 | 0.53 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.47 |
| ▸ | HTT | P42858 | 1/20 | 0.47 |
| ▸ | PDE4B | Q07343 | 1/20 | 0.47 |
| ▸ | TSHR | P16473 | 1/20 | 0.46 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.45 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.43 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.43 |
| ▸ | MAOB | P27338 | 2/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.43 |
| ▸ | MEN1 | O00255 | 2/20 | 0.43 |
| ▸ | TP53 | P04637 | 1/20 | 0.43 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.42 |
| ▸ | SMPD1 | P17405 | 3/20 | 0.42 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13325333 | 0.89 | CYP2B6 (0.52) | CYP2B6L3MBTL1HTTPDE4BTSHR | |
| SCHEMBL3284929 | 0.88 | CYP2B6 (0.55) | CYP2B6L3MBTL1HTTPDE4BTSHR | |
| SCHEMBL3288060 | 0.83 | CYP2B6 (0.51) | CYP2B6L3MBTL1HTTPDE4BTSHR | |
| SCHEMBL3305409 | 0.82 | CYP2B6 (0.50) | CYP2B6L3MBTL1HTTPDE4BTSHR | |
| SCHEMBL3288790 | 0.81 | CYP2B6 (0.56) | CYP2B6PDE4BTSHRMAPK1MAOB | |
| SCHEMBL3284931 | 0.81 | TAS1R3 (0.55) | CYP2B6HTTPDE4BTSHRMAPK1 | |
| SCHEMBL13325328 | 0.81 | CYP2B6 (0.53) | CYP2B6L3MBTL1PDE4BKMT2AMEN1 | |
| SCHEMBL668221 | 0.80 | MAPT (0.59) | CYP2B6PDE4BTSHRMAPK1MAOB | |
| SCHEMBL3286749 | 0.80 | CYP2B6 (0.48) | CYP2B6L3MBTL1HTTPDE4BTSHR | |
| SCHEMBL2291871 | 0.80 | CYP2B6 (0.52) | CYP2B6L3MBTL1PDE4BKMT2AMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7714168-B2 | N-(1,1-diemthylpropyl)-4-(2-propynyloxy)-3-methoxybenzamide; N-(2,2-diemthylpropyl)-4-(2-propynyloxy)-3-methoxybenzamide; controlling plant diseases | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2010-05-11 | — | — | US | disclosed |
| EP-1940779-B1 | AMIDE COMPOUNDS AND THEIR USE | SUMITOMO CHEMICAL CO (JP) | 2009-07-22 | — | — | EP | disclosed |
| US-20080319080-A1 | Amide Compounds and Their Use | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2008-12-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080319080-A1 | Amide Compounds and Their Use | NAT1, ACAT2, NAAA | CYP2B6 2549/4885L3MBTL1 1117/4885HTT 1696/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.